<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>The Nevada National Board Professional Learning Institute | Coyne | Activity</title>
	<link>http://www.nationalboardinstitute.com/members/waterbrandy81/activity/</link>
	<atom:link href="http://www.nationalboardinstitute.com/members/waterbrandy81/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Coyne.</description>
	<lastBuildDate>Fri, 23 May 2025 17:06:54 -0700</lastBuildDate>
	<generator>https://buddypress.org/?v=9.1.1</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">2c06b6b3b369c34c497780955562b019</guid>
				<title>Coyne posted an update: The present study aimed at exploring the sources of salinity [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/41893/</link>
				<pubDate>Sat, 08 Feb 2025 11:28:09 -0800</pubDate>

									<content:encoded><![CDATA[<p>The present study aimed at exploring the sources of salinity and the link it shares with the enrichment of As (arsenic) and F- (fluoride) in the groundwater of Rachna Doab. Total Dissolved Solids (TDS) were used as the measure of salinity to classify samples into three groups TDS less then 1000 mg/L (freshwater), 1000-3000 mg/L (slightly saline)&hellip;<span class="activity-read-more" id="activity-read-more-41893"><a href="http://www.nationalboardinstitute.com/activity/p/41893/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">13328cb0d457452c325479d6c728417e</guid>
				<title>Coyne posted an update: © BMJ Publishing Group Limited 2020. No commercial re-use. [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/40336/</link>
				<pubDate>Thu, 06 Feb 2025 15:48:57 -0800</pubDate>

									<content:encoded><![CDATA[<p>© BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.A 59-year-old man, with a background of multiply relapsed myeloma, presented with a 3-week history of confusion, short-term memory impairment and behavioural changes. CT head showed bilateral white matter changes and numerous, large lytic&hellip;<span class="activity-read-more" id="activity-read-more-40336"><a href="http://www.nationalboardinstitute.com/activity/p/40336/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">5edd0aa54b320708a1a063108e96807a</guid>
				<title>Coyne posted an update: Its pathophysiology is still indeterminate but together with [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/36731/</link>
				<pubDate>Sun, 02 Feb 2025 11:47:34 -0800</pubDate>

									<content:encoded><![CDATA[<p>Its pathophysiology is still indeterminate but together with its clinical picture, may mimic Inflammatory Bowel Disease. Treatment includes a high fibre diet together with antibiotics and/or salicylates with surgery in severe cases. Indications for elective surgery in diverticular disease have changed over the past decades as this may not suggest&hellip;<span class="activity-read-more" id="activity-read-more-36731"><a href="http://www.nationalboardinstitute.com/activity/p/36731/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">f9b936c4d1099348f75807ed9c70638a</guid>
				<title>Coyne posted an update: This will be the first study to evaluate the add-on effect [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/34780/</link>
				<pubDate>Fri, 31 Jan 2025 11:29:13 -0800</pubDate>

									<content:encoded><![CDATA[<p>This will be the first study to evaluate the add-on effect of PCSK9i on endothelial function of T2DM patients under regular use of empagliflozin.</p>
<p> ClinicalTrials.gov identifier NCT03932721.</p>
<p>ClinicalTrials.gov identifier NCT03932721.</p>
<p> In Taiwan, approximately 90% of patients with end-stage renal disease receive maintenance&hellip;<span class="activity-read-more" id="activity-read-more-34780"><a href="http://www.nationalboardinstitute.com/activity/p/34780/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">83adaeaeddaca16f0ff46ca3e77051a7</guid>
				<title>Coyne posted an update: 86 (0.80-0.93)], and no effect in at-risk patients without [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/29483/</link>
				<pubDate>Tue, 28 Jan 2025 13:12:21 -0800</pubDate>

									<content:encoded><![CDATA[<p>86 (0.80-0.93)], and no effect in at-risk patients without history of cardiovascular events [GLP1-RA 0.94 (0.82-1.07); SGLT-2i 1.00 (0.87-1.16)]. We observed a trend toward larger treatment benefits with SGLT-2i among patients with chronic kidney disease [0.82 (0.69-0.97)], and patients with uncontrolled diabetes for both GLP1-RA or SGLT-2i&hellip;<span class="activity-read-more" id="activity-read-more-29483"><a href="http://www.nationalboardinstitute.com/activity/p/29483/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">889b4380a03690455e40f34b035549fd</guid>
				<title>Coyne became a registered member</title>
				<link>http://www.nationalboardinstitute.com/activity/p/29453/</link>
				<pubDate>Tue, 28 Jan 2025 13:10:27 -0800</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>